TrialCurrent vascular pharmacology2025

Efficacy and Safety of Sarpogrelate on Symptom Improvement in Patients with Peripheral Arterial Disease (PAD) and/or Being at Risk of PAD: A Single Arm, Multi-Centered, Open-Label Trial.

Jong Chul Won et al.PubMed ↗Publisher ↗

No numbers read from the abstract.